Laser therapy aims to preserve sight in AMD patients
NCT ID NCT07607496
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a targeted laser treatment, called photothermal therapy, can slow the progression of intermediate age-related macular degeneration (AMD). About 240 people aged 60–90 with intermediate AMD will receive either the laser or a sham procedure. The main goal is to see if the treatment preserves the health of light-sensing cells in the eye over 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
photothermal therapy (laser treatment)
What this could lead to
If successful, this laser treatment could slow the progression of intermediate AMD and help preserve vision longer.
What could go wrong
This is an early-stage trial with no phase assigned, so results are uncertain. The treatment may not slow vision loss or could cause side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTERMEDIATE AMD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AugenNord Medical Practice and Surgical Center
RECRUITINGSchleswig, 24837, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Ophthalmology at Hannover Medical School
NOT_YET_RECRUITINGHanover, 30625, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Ophthalmology, University Medical Center Schleswig-Holstein
NOT_YET_RECRUITINGLübeck, 23538, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Potsdam Eye Clinic at Gräfehaus
NOT_YET_RECRUITINGPotsdam, 14467, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••